Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TVTX | AZN | AMGN | GILD | BMY |
| Company | Travere Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 45.51 | 184.37 | 330.39 | 136.49 | 56.44 |
| High | 45.97 | 184.37 | 331.28 | 136.49 | 56.90 |
| Low | 42.18 | 181.03 | 327.22 | 133.76 | 55.57 |
| Latest | 42.66 | 182.52 | 329.09 | 134.06 | 56.25 |
| Change | -2.10 | -2.40 | -2.02 | -2.24 | -0.34 |
| % Change | -4.69% | -1.30% | -0.61% | -1.64% | -0.60% |
| Volume | 10,827,600 | 2,749,500 | 3,296,900 | 8,901,000 | 10,419,700 |
| 20-Day Average Volume | 3,398,495 | 2,077,455 | 2,660,010 | 5,782,930 | 10,174,075 |
| Previous Close | 44.76 | 184.92 | 331.11 | 136.30 | 56.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 40.44 | 192.71 | 342.31 | 134.27 | 58.32 |
| 20-Day Raw Stochastic | 70.72% | 9.23% | 23.20% | 43.55% | 13.05% |
| 20-Day Relative Strength | 62.87 | 39.41 | 39.85 | 46.28 | 42.90 |
| Weighted Alpha | +76.27 | +27.12 | +17.51 | +30.95 | +20.58 |
| Today's Opinion | 100% Buy | 8% Buy | 8% Sell | 8% Buy | 24% Buy |
| Previous Opinion | 100% Buy | 8% Buy | 8% Sell | 24% Buy | 24% Buy |
| Last Month's Opinion | 24% Buy | 88% Buy | 40% Buy | 56% Buy | 64% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.28% since 04/30/26 | -2.59% since 04/30/26 | -4.96% since 04/30/26 | +2.46% since 04/30/26 | -7.16% since 04/30/26 |
| Low | 42.08 on 05/01/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 129.01 on 05/01/26 | 55.57 on 05/07/26 |
| High | 48.61 on 05/05/26 | 187.18 on 05/01/26 | 337.00 on 05/01/26 | 136.75 on 05/06/26 | 60.08 on 05/01/26 |
| 1-Month | |||||
| %Chg | +34.70% since 04/07/26 | -9.11% since 04/07/26 | -3.21% since 04/07/26 | -3.41% since 04/07/26 | -2.46% since 04/07/26 |
| Low | 28.29 on 04/10/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.57 on 05/07/26 |
| High | 48.61 on 05/05/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +43.59% since 02/06/26 | -5.44% since 02/06/26 | -14.37% since 02/06/26 | -12.09% since 02/06/26 | -9.26% since 02/06/26 |
| Low | 26.15 on 03/20/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.57 on 05/07/26 |
| High | 48.61 on 05/05/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +31.91% since 11/07/25 | +7.90% since 11/07/25 | +2.78% since 11/07/25 | +12.81% since 11/07/25 | +20.48% since 11/07/25 |
| Low | 22.59 on 01/13/26 | 171.69 on 11/10/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 48.61 on 05/05/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,162,366 | 286,793,888 | 178,695,104 | 169,178,560 | 115,560,800 |
| Shares Outstanding, K | 92,993 | 1,550,908 | 539,685 | 1,241,222 | 2,042,071 |
| Annual Sales | 490,730,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -25,550,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 129,690,000 | 15,288,000,000 | 8,618,000,000 | 7,925,000,000 | 11,489,000,000 |
| Last Quarter Net Income | 2,730,000 | 3,080,000,000 | 1,819,000,000 | 2,183,000,000 | 2,677,000,000 |
| 60-Month Beta | 1.13 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 05/04/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 1.86 on 02/10/26 | 1.58 on 04/30/26 |
| Earnings Date | 08/05/26 | 08/04/26 | 08/04/26 | 05/07/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.57 | 14.91 | 16.38 | 9.60 |